stockportfolio.pro
Abbott Laboratories Gross Profit 2007–2025
Abbott Laboratories (ABT) annual gross profit by fiscal year, computed from SEC filings. Compound growth +3.1%/yr over 18 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $25.01B | 56.4% | +7.6% |
| FY 2024 | $23.24B | 55.4% | +5.0% |
| FY 2023 | $22.13B | 55.2% | -9.7% |
| FY 2022 | $24.51B | 56.1% | -0.1% |
| FY 2021 | $24.54B | 57.0% | +25.2% |
| FY 2020 | $19.61B | 56.6% | +5.0% |
| FY 2019 | $18.67B | 58.5% | +4.5% |
| FY 2018 | $17.87B | 58.4% | +19.3% |
| FY 2017 | $14.98B | 54.7% | +27.4% |
| FY 2016 | $11.76B | 56.4% | +0.9% |
| FY 2015 | $11.66B | 57.1% | +5.7% |
| FY 2014 | $11.03B | 54.5% | +5.4% |
| FY 2013 | $10.46B | 53.2% | +3.1% |
| FY 2012 | $10.15B | 53.3% | -10.9% |
| FY 2011 | $11.39B | 53.2% | -44.4% |
| FY 2010 | $20.50B | 58.3% | +16.8% |
| FY 2009 | $17.56B | 57.1% | +3.8% |
| FY 2008 | $16.92B | 57.3% | +16.7% |
| FY 2007 | $14.49B | 55.9% | — |
Source: Abbott Laboratories SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's gross profit?
Abbott Laboratories (ABT) reported gross profit of $25.01B for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's gross profit changed over time?
Between fiscal 2007 and 2025, ABT's gross profit grew at roughly 3.1% per year (compound annual rate), from $14.49B to $25.01B.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.